The DOI matches its Crossref record; 418 of the 418 references it cites were found in a registry or an index.
Drug allergy: A 2022 practice parameter update
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A method for estimating the probability of adverse drug reactions
Naranjo, C. A., Busto, U., Sellers, E. M., Sandor, P., Ruiz, I., Roberts, E. A., Janecek, E., Domecq, C., & Greenblatt, D. J. (1981) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1981.154 · Cited by 11,914
Barlam, T. F., Cosgrove, S. E., Abbo, L. M., MacDougall, C., Schuetz, A. N., Septimus, E. J., Srinivasan, A., Dellit, T. H., Falck-Ytter, Y. T., Fishman, N. O., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw118 · Cited by 3,061
McLaughlin, P., Grillo-López, A. J., Link, B. K., Levy, R., Czuczman, M. S., Williams, M. E., Heyman, M. R., Bence-Bruckler, I., White, C. A., Cabanillas, F., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2825 · Cited by 2,755
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
Johnson, D. B., Balko, J. M., Compton, M. L., Chalkias, S., Gorham, J., Xu, Y., Hicks, M., Puzanov, I., Alexander, M. R., Bloomer, T. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1609214 · Cited by 2,308
Self-citationTRY plant trait database – enhanced coverage and open access
Kattge, J., Bönisch, G., Díaz, S., Lavorel, S., Prentice, I. C., Leadley, P., Tautenhahn, S., Werner, G. D. A., Aakala, T., Abedi, M., et al. (2020) · Global Change Biology · doi:10.1111/gcb.14904 · Cited by 2,089
HLA-B*5701 Screening for Hypersensitivity to Abacavir
Mallal, S., Phillips, E., Carosi, G., Molina, J.-M., Workman, C., Tomažič, J., Jägel-Guedes, E., Rugina, S., Kozyrev, O., Cid, J. F., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706135 · Cited by 1,835
Self-citationA marker for Stevens–Johnson syndrome
Chung, W.-H., Hung, S.-I., Hong, H.-S., Hsih, M.-S., Yang, L.-C., Ho, H.-C., Wu, J.-Y., & Chen, Y.-T. (2004) · Nature · doi:10.1038/428486a · Cited by 1,753
Maloney, D. G., Grillo-López, A. J., White, C. A., Bodkin, D., Schilder, R. J., Neidhart, J. A., Janakiraman, N., Foon, K. A., Liles, T.-M., Dallaire, B. K., et al. (1997) · Blood · doi:10.1182/blood.v90.6.2188 · Cited by 1,733
Bastuji‐Garin, S. (1993) · Archives of Dermatology · doi:10.1001/archderm.129.1.92 · Cited by 1,697
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
Chung, C. H., Mirakhur, B., Chan, E., Le, Q.-T., Berlin, J., Morse, M., Murphy, B. A., Satinover, S. M., Hosen, J., Mauro, D., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074943 · Cited by 1,521
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
Hung, S.-I., Chung, W.-H., Liou, L.-B., Chu, C.-C., Lin, M., Huang, H.-P., Lin, Y.-L., Lan, J.-L., Yang, L.-C., Hong, H.-S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409500102 · Cited by 1,284
Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions
McNeil, B. D., Pundir, P., Meeker, S., Han, L., Undem, B. J., Kulka, M., & Dong, X. (2015) · Nature · doi:10.1038/nature14022 · Cited by 1,228
Mockenhaupt, M., Viboud, C., Dunant, A., Naldi, L., Halevy, S., Bavinck, J. N. B., Sidoroff, A., Schneck, J., Roujeau, J.-C., & Flahault, A. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701033 · Cited by 1,017
Kardaun, S. H., Sekula, P., Valeyrie-Allanore, L., Liss, Y., Chu, C. Y., Creamer, D., Sidoroff, A., Naldi, L., Mockenhaupt, M., Roujeau, J. C., et al. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12501 · Cited by 1,010
Drug Allergy: An Updated Practice Parameter
(2010) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2010.08.002 · Cited by 957
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
study, F. T. D., Daly, A. K., International SAE Consortium, Donaldson, P. T., Bhatnagar, P., Shen, Y., Pe'er, I., Floratos, A., Daly, M. J., Goldstein, D. B., et al. (2009) · Nature Genetics · doi:10.1038/ng.379 · Cited by 944
International Con sensus on drug allergy
Demoly, P., Adkinson, N. F., Brockow, K., Castells, M., Chiriac, A. M., Greenberger, P. A., Khan, D. A., Lang, D. M., Park, H. ‐., Pichler, W., et al. (2014) · Allergy · doi:10.1111/all.12350 · Cited by 935
Self-citationBrahmer, J. R., Abu-Sbeih, H., Ascierto, P. A., Brufsky, J., Cappelli, L. C., Cortazar, F. B., Gerber, D. E., Hamad, L., Hansen, E., Johnson, D. B., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002435 · Cited by 917
Food allergy: A practice parameter update—2014
Sampson, H. A., Aceves, S., Bock, S. A., James, J., Jones, S., Lang, D., Nadeau, K., Nowak-Wegrzyn, A., Oppenheimer, J., Perry, T. T., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.05.013 · Cited by 845
Self-citationMacy, E., & Contreras, R. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.021 · Cited by 829
Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations
Aberer, W., Bircher, A., Romano, A., Blanca, M., Campi, P., Fernandez, J., Brockow, K., Pichler, W. J., Demoly, P., for, E. N. D. A., et al. (2003) · Allergy · doi:10.1034/j.1398-9995.2003.00279.x · Cited by 822
Brockow, K., Garvey, L. H., Aberer, W., Atanaskovic‐Markovic, M., Barbaud, A., Bilo, M. B., Bircher, A., Blanca, M., Bonadonna, B., Campi, P., et al. (2013) · Allergy · doi:10.1111/all.12142 · Cited by 813
Sensory Neuron-Specific GPCR Mrgprs Are Itch Receptors Mediating Chloroquine-Induced Pruritus
Liu, Q., Tang, Z., Surdenikova, L., Kim, S., Patel, K. N., Kim, A., Ru, F., Guan, Y., Weng, H.-J., Geng, Y., et al. (2009) · Cell · doi:10.1016/j.cell.2009.11.034 · Cited by 813
Sassolas, B., Haddad, C., Mockenhaupt, M., Dunant, A., Liss, Y., Bork, K., Haustein, U. F., Vieluf, D., Roujeau, J. C., & Le Louet, H. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.252 · Cited by 758
Allergy Diagnostic Testing: An Updated Practice Parameter
Bernstein, I. L., Li, J. T., Bernstein, D. I., Hamilton, R., Spector, S. L., Tan, R., Sicherer, S., Golden, D. B. K., Khan, D. A., Nicklas, R. A., et al. (2008) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)60305-5 · Cited by 723
Self-citationShaker, M. S., Wallace, D. V., Golden, D. B. K., Oppenheimer, J., Bernstein, J. A., Campbell, R. L., Dinakar, C., Ellis, A., Greenhawt, M., Khan, D. A., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.01.017 · Cited by 715
Self-citationCarbamazepine-Induced Toxic Effects and HLA-B*1502 Screening in Taiwan
Chen, P., Lin, J.-J., Lu, C.-S., Ong, C.-T., Hsieh, P. F., Yang, C.-C., Tai, C.-T., Wu, S.-L., Lu, C.-H., Hsu, Y.-C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009717 · Cited by 711
Blumenthal, K. G., Peter, J. G., Trubiano, J. A., & Phillips, E. J. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32218-9 · Cited by 614
Self-citationCastells, M. C., Tennant, N. M., Sloane, D. E., Ida Hsu, F., Barrett, N. A., Hong, D. I., Laidlaw, T. M., Legere, H. J., Nallamshetty, S. N., Palis, R. I., et al. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.02.044 · Cited by 600
Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer
Dolladille, C., Ederhy, S., Sassier, M., Cautela, J., Thuny, F., Cohen, A. A., Fedrizzi, S., Chrétien, B., Da-Silva, A., Plane, A.-F., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.0726 · Cited by 587
Natural history of aspirin-induced asthma
Szczeklik, A., Niżankowska, E., Duplaga, M., & the Aiane Investigators, O. B. O. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.016003432.x · Cited by 550
Idsøe, O., GUTHE, T., Willcox, R. R., & WECK, A. L. D. (1968) · Europe PMC (PubMed Central) · Cited by 540
Kowalski, M. L., Asero, R., Bavbek, S., Blanca, M., Blanca‐Lopez, N., Bochenek, G., Brockow, K., Campo, P., Celik, G., Cernadas, J., et al. (2013) · Allergy · doi:10.1111/all.12260 · Cited by 499
Barbaud, A., Gonçalo, M., Bruynzeel, D., & Bircher, A. (2001) · Contact Dermatitis · doi:10.1034/j.1600-0536.2001.450601.x · Cited by 498
The incidence and management of infusion reactions to infliximab: a large center experience
Cheifetz, A. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00231-4 · Cited by 491
The impact of a reported penicillin allergy on surgical site infection risk.
Blumenthal, K. G., Ryan, E. E., Li, Y., Lee, H., Kuhlen, J. L., & Shenoy, E. S. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix794 · Cited by 481
Self-citationKowalski, M. L., Makowska, J. S., Blanca, M., Bavbek, S., Bochenek, G., Bousquet, J., Bousquet, P., Celik, G., Demoly, P., Gomes, E. R., et al. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02557.x · Cited by 465
Banerji, A., Wickner, P. G., Saff, R., Stone, C. A., Robinson, L. B., Long, A. A., Wolfson, A. R., Williams, P., Khan, D. A., Phillips, E., et al. (2021) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2020.12.047 · Cited by 452
Self-citationLacouture, M. E., Anadkat, M. J., Bensadoun, R.-J., Bryce, J., Chan, A., Epstein, J. B., Eaby-Sandy, B., Murphy, B. A., & MASCC Skin Toxicity Study Group (2011) · Supportive Care in Cancer · doi:10.1007/s00520-011-1197-6 · Cited by 444
Lucena, M. I., Molokhia, M., Shen, Y., Urban, T. J., Aithal, G. P., Andrade, R. J., Day, C. P., Ruiz–Cabello, F., Donaldson, P. T., Stephens, C., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.001 · Cited by 442
Rajan, J. P., Wineinger, N. E., Stevenson, D. D., & White, A. A. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.08.020 · Cited by 426
Self-citationThompson, J. A., Schneider, B. J., Brahmer, J., Achufusi, A., Armand, P., Berkenstock, M. K., Bhatia, S., Budde, L. E., Chokshi, S., Davies, M., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0020 · Cited by 426
Saag, M., Balu, R., Phillips, E., Brachman, P., Martorell, C., Burman, W., Stancil, B., Mosteller, M., Brothers, C., Wannamaker, P., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/529382 · Cited by 425
Self-citationImmediate Hypersensitivity Reactions to Beta-Lactam Antibiotics
SAXON, A., BEALL, G. N., ROHR, A. S., & ADELMAN, D. C. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-204 · Cited by 412
Fatal anaphylaxis in the United States, 1999-2010: Temporal patterns and demographic associations
Jerschow, E., Lin, R. Y., Scaperotti, M. M., & McGinn, A. P. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.08.018 · Cited by 403
Barbaud, A., Collet, E., Milpied, B., Assier, H., Staumont, D., Avenel-Audran, M., Grange, A., Amarger, S., Girardin, P., Guinnepain, M.-T., et al. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12125 · Cited by 398
Maintaining safety with SARS-CoV-2 vaccines
Castells, M. C., & Phillips, E. J. (2021) · New England Journal of Medicine · doi:10.1056/nejmra2035343 · Cited by 395
Pollack, M. H., Betof, A., Dearden, H., Rapazzo, K., Valentine, I., Brohl, A. S., Ancell, K. K., Long, G. V., Menzies, A. M., Eroglu, Z., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdx642 · Cited by 393
Development and Validation of a Penicillin Allergy Clinical Decision Rule
Trubiano, J. A., Vogrin, S., Chua, K. Y. L., Bourke, J., Yun, J., Douglas, A., Stone, C. A., Yu, R., Groenendijk, L., Holmes, N. E., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0403 · Cited by 388
Self-citationThe lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity
NYFELER, B., & PICHLER, W. J. (1997) · Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy · doi:10.1046/j.1365-2222.1997.d01-495.x · Cited by 387
Clinical Features of Hypersensitivity Reactions to Carboplatin
Markman, M., Kennedy, A., Webster, K., Elson, P., Peterson, G., Kulp, B., & Belinson, J. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.4.1141 · Cited by 365
Blumenthal, K. G., Lu, N., Zhang, Y., Li, Y., Walensky, R. P., & Choi, H. K. (2018) · BMJ · doi:10.1136/bmj.k2400 · Cited by 357
Self-citationImmediate‐type hypersensitivity to polyethylene glycols: a review
Wenande, E., & Garvey, L. H. (2016) · Clinical & Experimental Allergy · doi:10.1111/cea.12760 · Cited by 354
Stone, C. A., Liu, Y., Relling, M. V., Krantz, M. S., Pratt, A. L., Abreo, A., Hemler, J. A., & Phillips, E. J. (2019) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2018.12.003 · Cited by 351
Self-citationAbsence of Cross-Reactivity between Sulfonamide Antibiotics and Sulfonamide Nonantibiotics
Strom, B. L., Schinnar, R., Apter, A. J., Margolis, D. J., Lautenbach, E., Hennessy, S., Bilker, W. B., & Pettitt, D. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022963 · Cited by 349
Caubet, J.-C., Kaiser, L., Lemaître, B., Fellay, B., Gervaix, A., & Eigenmann, P. A. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.08.025 · Cited by 345
Clinical experience with penicillin skin testing in a large inner-city STD clinic.
Gadde, J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510200062033 · Cited by 344
Sogn, D. D. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.1992.00400170105020 · Cited by 337
Nanda, K. S., Cheifetz, A. S., & Moss, A. C. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.363 · Cited by 336
Berges-Gimeno, M. P., Simon, R. A., & Stevenson, D. D. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.7 · Cited by 333
Phillips, E. J., Sukasem, C., Whirl‐Carrillo, M., Müller, D. J., Dunnenberger, H. M., Chantratita, W., Goldspiel, B., Chen, Y., Carleton, B. C., George, A. L., et al. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1004 · Cited by 328
Self-citationSkin testing to detect penicillin allergy
Sullivan, T. J., Wedner, H. J., Shatz, G. S., Yecies, L. D., & Parker, C. W. (1981) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(81)90180-9 · Cited by 325
Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma
Sanak, M., Simon, H.-U., & Szczeklik, A. (1997) · The Lancet · doi:10.1016/s0140-6736(05)64015-9 · Cited by 325
Natural evolution of skin test sensitivity in patients allergic to β-lactam antibiotics
Blanca, M., Torres, M. J., García, J. J., Romano, A., Mayorga, C., de Ramon, E., Vega, J. M., Miranda, A., & Juarez, C. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70439-2 · Cited by 317
Self-reported antibiotic allergy incidence and prevalence: age and sex effects.
Macy, E., & Poon K-Y, T. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.01.034 · Cited by 313
Drug allergies documented in electronic health records of a large healthcare system
Zhou, L., Dhopeshwarkar, N., Blumenthal, K. G., Goss, F., Topaz, M., Slight, S. P., & Bates, D. W. (2016) · Allergy · doi:10.1111/all.12881 · Cited by 312
Self-citationHLA-B*13:01 and the Dapsone Hypersensitivity Syndrome
Zhang, F.-R., Liu, H., Irwanto, A., Fu, X.-A., Li, Y., Yu, G.-Q., Yu, Y.-X., Chen, M.-F., Low, H.-Q., Li, J.-H., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213096 · Cited by 310
Self-citationMill, C., Primeau, M.-N., Medoff, E., Lejtenyi, C., O’Keefe, A., Netchiporouk, E., Dery, A., & Ben-Shoshan, M. (2016) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2016.0033 · Cited by 302
Messaad, D., Sahla, H., Benahmed, S., Godard, P., Bousquet, J., & Demoly, P. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-12-200406150-00009 · Cited by 299
Genetic Variants Associated With Phenytoin-Related Severe Cutaneous Adverse Reactions
Chung, W.-H., Chang, W.-C., Lee, Y.-S., Wu, Y.-Y., Yang, C.-H., Ho, H.-C., Chen, M.-J., Lin, J.-Y., Hui, R. C.-Y., Ho, J.-C., et al. (2014) · JAMA · doi:10.1001/jama.2014.7859 · Cited by 297
Impact of Reported Beta-Lactam Allergy on Inpatient Outcomes: A Multicenter Prospective Cohort Study
MacFadden, D. R., LaDelfa, A., Leen, J., Gold, W. L., Daneman, N., Weber, E., Al-Busaidi, I., Petrescu, D., Saltzman, I., Devlin, M., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw462 · Cited by 296
Brennan, P. J., Bouza, T. R., Hsu, F. I., Sloane, D. E., & Castells, M. C. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.09.009 · Cited by 283
Sacco, K. A., Bates, A., Brigham, T. J., Imam, J. S., & Burton, M. C. (2017) · Allergy · doi:10.1111/all.13168 · Cited by 283
Macy, E., & Ngor, E. W. (2013) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2013.02.002 · Cited by 275
Castells, M., Khan, D. A., & Phillips, E. J. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1807761 · Cited by 270
Self-citationHypersensitivity reactions to therapeutic monoclonal antibodies: Phenotypes and endotypes
Isabwe, G. A. C., Garcia Neuer, M., de las Vecillas Sanchez, L., Lynch, D.-M., Marquis, K., & Castells, M. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.02.018 · Cited by 265
Romano, A., Valluzzi, R. L., Caruso, C., Maggioletti, M., Quaratino, D., & Gaeta, F. (2018) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2018.01.020 · Cited by 252
Caudle, K. E., Rettie, A. E., Whirl-Carrillo, M., Smith, L. H., Mintzer, S., Lee, M. T. M., Klein, T. E., & Callaghan, J. T. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.159 · Cited by 243
Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes
Stevenson, D. D., Sanchez-Borges, M., & Szczeklik, A. (2001) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)62221-1 · Cited by 239
Infliximab-Related Infusion Reactions: Systematic Review
Lichtenstein, L., Ron, Y., Kivity, S., Ben-Horin, S., Israeli, E., Fraser, G. M., Dotan, I., Chowers, Y., Confino-Cohen, R., & Weiss, B. (2015) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjv096 · Cited by 239
Ponvert, C., Perrin, Y., Bados‐Albiero, A., Le Bourgeois, M., Karila, C., Delacourt, C., scheinmann, P., & De Blic, J. (2011) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2011.01169.x · Cited by 236
Torres, J., Romano, A., Mayorga, C., Carmen, M., Guzman, A. E., Reche, M., Juarez, C., & Blanca, M. (2001) · Allergy · doi:10.1034/j.1398-9995.2001.00089.x · Cited by 235
Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs
Broyles, A. D., Banerji, A., Barmettler, S., Biggs, C. M., Blumenthal, K., Brennan, P. J., Breslow, R. G., Brockow, K., Buchheit, K. M., Cahill, K. N., et al. (2020) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2020.08.006 · Cited by 235
Self-citationComparative Tolerability of the Newer Fluoroquinolone Antibacterials
Ball, P., Mandell, L., Niki, Y., & Tillotson, G. (1999) · Drug Safety · doi:10.2165/00002018-199921050-00005 · Cited by 228
Penicillin allergy: clinical experience with a battery of skin-test reagents
Solley, G. O., Gleich, G. J., & Van Dellen, R. G. (1982) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(82)90105-1 · Cited by 227
White, K. D., Chung, W.-H., Hung, S.-I., Mallal, S., & Phillips, E. J. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.05.050 · Cited by 227
Self-citationPolyethylene Glycol–Induced Systemic Allergic Reactions (Anaphylaxis)
Sellaturay, P., Nasser, S., & Ewan, P. (2021) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2020.09.029 · Cited by 225
Non‐IgE mediated mast cell activation
Redegeld, F. A., Yu, Y., Kumari, S., Charles, N., & Blank, U. (2018) · Immunological Reviews · doi:10.1111/imr.12629 · Cited by 213
Green, G. R., Rosenblum, A. H., & Sweet, L. C. (1977) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(77)90064-1 · Cited by 212
Safety, Costs, and Efficacy of Rapid Drug Desensitizations to Chemotherapy and Monoclonal Antibodies
Sloane, D., Govindarajulu, U., Harrow-Mortelliti, J., Barry, W., Hsu, F. I., Hong, D., Laidlaw, T., Palis, R., Legere, H., Bunyavanich, S., et al. (2016) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2015.12.019 · Cited by 211
Prediction of penicillin allergy by immunological tests
Levine, B. B., & Zolov, D. M. (1969) · Journal of Allergy · doi:10.1016/0021-8707(69)90066-5 · Cited by 206
Nonirritating Intradermal Skin Test Concentrations for Commonly Prescribed Antibiotics
Empedrad, R. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(03)00029-0 · Cited by 205
Pichichero, M. E., & Pichichero, D. M. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70499-8 · Cited by 200
Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma
Stevenson, D. D., & Simon, R. A. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.116290 · Cited by 200
Overview, prevention and management of chemotherapy extravasation
Kreidieh, F. Y. (2016) · World Journal of Clinical Oncology · doi:10.5306/wjco.v7.i1.87 · Cited by 197
Chung, W.-H., Chang, W.-C., Stocker, S. L., Juo, C.-G., Graham, G. G., Lee, M.-H. H., Williams, K. M., Tian, Y.-C., Juan, K.-C., Jan Wu, Y.-J., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205577 · Cited by 195
Blanca, M., VEGA, J. M., GARCIA, J., CARMONA, M. J., Terrados, S., Ávila, M. J., Miranda, A., & JUAREZ, C. (1990) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1990.tb03139.x · Cited by 194
Contact Dermatitis: A Practice Parameter–Update 2015
Fonacier, L. S., Bernstein, D. I., Pacheco, K., Holness, D. L., Blessing-Moore, J., Khan, D. A., Lang, D. M., Nicklas, R. A., Oppenheimer, J. J., Portnoy, J. M., et al. (2015) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2015.02.009 · Cited by 188
Self-citationBlumenthal, K. G., Shenoy, E. S., Varughese, C. A., Hurwitz, S., Hooper, D. C., & Banerji, A. (2015) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2015.05.011 · Cited by 185
Self-citationRomano, A., Guéant-Rodriguez, R.-M., Viola, M., Pettinato, R., & Guéant, J.-L. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-1-200407060-00010 · Cited by 184
Chen, Y.-C., Chang, C.-Y., Cho, Y.-T., Chiu, H.-C., & Chu, C.-Y. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2012.08.009 · Cited by 183
Routine elective penicillin allergy skin testing in children and adolescents: study of sensitization
Mendelson, L. M., Ressler, C., Rosen, J. P., & Selcow, J. E. (1984) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(84)90487-1 · Cited by 183
Muraro, A., Lemanske, R. F., Castells, M., Torres, M. J., Khan, D., Simon, H.-U., Bindslev-Jensen, C., Burks, W., Poulsen, L. K., Sampson, H. A., et al. (2017) · doi:10.7892/boris.95346 · Cited by 183
Self-citationWoo, M. H., Hak, L. J., Storm, M. C., Sandlund, J. T., Ribeiro, R. C., Rivera, G. K., Rubnitz, J. E., Harrison, P. L., Wang, B., Evans, W. E., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.7.1525 · Cited by 182
Immune‐mediated adverse reactions to vaccines
Stone, C. A., Rukasin, C. R. F., Beachkofsky, T. M., & Phillips, E. J. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14112 · Cited by 180
Self-citationJohnson, D. B., McDonnell, W. J., Gonzalez-Ericsson, P. I., Al-Rohil, R. N., Mobley, B. C., Salem, J.-E., Wang, D. Y., Sanchez, V., Wang, Y., Chastain, C. A., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0523-2 · Cited by 176
Aspirin Sensitivity: Implications for Patients With Coronary Artery Disease
Gollapudi, R. R., Teirstein, P. S., Stevenson, D. D., & Simon, R. A. (2004) · JAMA · doi:10.1001/jama.292.24.3017 · Cited by 174
Solensky, R., Earl, H. S., & Gruchalla, R. S. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.7.822 · Cited by 173
Self-citationKonvinse, K. C., Trubiano, J. A., Pavlos, R., James, I., Shaffer, C. M., Bejan, C. A., Schutte, R. J., Ostrov, D. A., Pilkinton, M. A., Rosenbach, M., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.01.045 · Cited by 173
Self-citationAspirin-Exacerbated Respiratory Disease — New Prime Suspects
Laidlaw, T. M., & Boyce, J. A. (2016) · New England Journal of Medicine · doi:10.1056/nejmcibr1514013 · Cited by 172
Multiple drug intolerance syndrome: prevalence, clinical characteristics, and management
Macy, E., & Ho, N. J. (2012) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2011.11.006 · Cited by 170
Re-visiting Hypersensitivity Reactions to Taxanes: A Comprehensive Review
Picard, M., & Castells, M. C. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-014-8416-0 · Cited by 169
Haanen, J., Ernstoff, M., Wang, Y., Menzies, A., Puzanov, I., Grivas, P., Larkin, J., Peters, S., Thompson, J., & Obeid, M. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000604 · Cited by 167
Imipenem cross-reactivity with penicillin in humans
Saxon, A., Adelman, D. C., Patel, A., Hajdu, R., & Calandra, G. B. (1988) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(88)91001-9 · Cited by 166
Peter, J., Lehloenya, R. J., Dlamini, S. K., Risma, K., White, K. D., Konvinse, K. C., & Phillips, E. J. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2017.01.025 · Cited by 164
Self-citationAranda, A., Mayorga, C., Ariza, A., Doña, I., Rosado, A., Blanca-Lopez, N., Andreu, I., & Torres, M. J. (2011) · Allergy · doi:10.1111/j.1398-9995.2010.02460.x · Cited by 163
Wolfson, A. R., Zhou, L., Li, Y., Phadke, N. A., Chow, O. A., & Blumenthal, K. G. (2018) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2018.08.013 · Cited by 163
Self-citationDiagnosing nonimmediate reactions to cephalosporins
Romano, A., Gaeta, F., Valluzzi, R. L., Caruso, C., Alonzi, C., Viola, M., & Bousquet, P. J. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.12.995 · Cited by 162
Lee, C.-W., Matulonis, U. A., & Castells, M. C. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.08.002 · Cited by 162
Dupilumab improves nasal polyp burden and asthma control in patients with CRSwNP and AERD
Laidlaw, T. M., Mullol, J., Fan, C., Zhang, D., Amin, N., Khan, A., Chao, J., & Mannent, L. P. (2019) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2019.03.044 · Cited by 161
Effect of salicylates in urticaria.
Moore-Robinson, M., & Warin, R. P. (1967) · BMJ · doi:10.1136/bmj.4.5574.262 · Cited by 160
O’Meara, S., Nanda, K. S., & Moss, A. C. (2014) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000436951.80898.6d · Cited by 160
MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia
Navinés‐Ferrer, A., Serrano‐Candelas, E., Lafuente, A., Muñoz‐Cano, R., Martı́n, M., & Gastaminza, G. (2018) · Scientific Reports · doi:10.1038/s41598-018-29965-8 · Cited by 160
Yuan, J., Guo, S. J., Hall, D. B., Cammett, A. M., Jayadev, S., Distel, M., Storfer, S. P., Huang, Z., Mootsikapun, P., Ruxrungtham, K., et al. (2011) · AIDS · doi:10.1097/qad.0b013e32834779df · Cited by 159
Cross-reactivity between a penicillin and a cephalosporin with the same side chain
Miranda, A., Blanca, M., Vega, J. M., Moreno, F., Carmona, M. J., García, J. J., Segurado, E., Justicia, J. L., & Juarez, C. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)70101-x · Cited by 158
Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper
Macy, E., Bernstein, J. A., Castells, M. C., Gawchik, S. M., Lee, T. H., Settipane, R. A., Simon, R. A., Wald, J., & Woessner, K. M. (2007) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)60692-8 · Cited by 158
Self-citationSafety and outcomes of oral graded challenges to amoxicillin without prior skin testing.
Iammatteo, M., Alvarez Arango, S., Ferastraoaru, D., Akbar, N., Lee, A. Y., Cohen, H. W., & Jerschow, E. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2018.05.008 · Cited by 157
Lee, J. Y., Simon, R. A., & Stevenson, D. D. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.09.011 · Cited by 157
Improving the Effectiveness of Penicillin Allergy De-labeling
Bourke, J., Pavlos, R. K., JAMES, I. R., & Phillips, E. J. (2015) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2014.11.002 · Cited by 156
Self-citationPrevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects
Settipane, R. A., Schrank, P. J., Simon, R. A., Mathison, D. A., Christiansen, S. C., & Stevenson, D. D. (1995) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(95)70290-3 · Cited by 156
Zanotti, K. M., Rybicki, L. A., KENNEDY, A. W., Belinson, J. L., Webster, K. D., Kulp, B., Peterson, G., & Markman, M. M. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.12.3126 · Cited by 155
Świerczyńska, M., Sanak, M., Bochenek, G., Stręk, P., Ćmiel, A., Gielicz, A., Plutecka, H., Szczeklik, A., & Niżankowska‐Mogilnicka, E. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.02.041 · Cited by 154
Feldweg, A. M., Lee, C.-W., Matulonis, U. A., & Castells, M. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.11.043 · Cited by 154
Macy, E., & Contreras, R. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.07.062 · Cited by 153
Incidence of Rash After Amoxicillin Treatment in Children With Infectious Mononucleosis
Sella, A. C., Ben‐Tov, A., Lahav, E., Mor, O., Rudich, H., Paret, G., & Reif, S. S. (2013) · PEDIATRICS · doi:10.1542/peds.2012-1575 · Cited by 153
A proactive approach to penicillin allergy testing in hospitalized patients.
Chen, J. R., Tarver, S. A., Alvarez, K. S., Tran, T., & Khan, D. A. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2016.09.045 · Cited by 152
Lack of allergic cross-reactivity to cephalosporins among patients allergic to penicillins.
Novalbos, A., Sastre, J., Cuesta, J., De Las Heras, M., Lluch‐Bernal, M., Bombín, C., & Quirce, S. (2001) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2001.00992.x · Cited by 151
Markman, M. M., Zanotti, K. M., Peterson, G., Kulp, B., Webster, K. D., & Belinson, J. L. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.539 · Cited by 150
Romano, A. G., Gaeta, F., Valluzzi, R. L., Maggioletti, M., Zaffiro, A., Caruso, C., & Quaratino, D. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.03.012 · Cited by 150
Jordhøy, M. S., Fayers, P. M., Loge, J. H., Saltnes, T., Ahlner‐Elmqvist, M., & Kaasa, S. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2116 · Cited by 150
Audicana, M. T., Bernaola, G., Urrutia, I., Echechipia, S., Gastaminza, G., Muñoz, D., Fernández, E., & de Corrés, L. F. (1994) · Allergy · doi:10.1111/j.1398-9995.1994.tb00809.x · Cited by 148
Rozsasi, A., Polzehl, D., Deutschle, T., Smith, E., Wiesmiller, K. M., Riechelmann, H., & Keck, T. (2008) · Allergy · doi:10.1111/j.1398-9995.2008.01658.x · Cited by 147
Polyzos, A., Tsavaris, N. B., Kosmas, C., Arnaouti, T., Kalahanis, N., Tsigris, C., Giannopoulos, A. G., Karatzas, G., Giannikos, L., & Sfikakis, P. P. (2001) · Oncology · doi:10.1159/000055363 · Cited by 147
Stevens, W. W., Jerschow, E., Baptist, A. P., Borish, L., Bosso, J. V., Buchheit, K. M., Cahill, K. N., Campo, P., Cho, S., Keswani, A., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.10.043 · Cited by 146
Self-citationUtility of patch testing in patients with hypersensitivity syndromes associated with abacavir
Phillips, E. J., Sullivan, J. R., Knowles, S. R., & Shear, N. H. (2002) · AIDS · doi:10.1097/00002030-200211080-00017 · Cited by 145
Self-citationPicard, M., Robitaille, G., Karam, F., Daigle, J.-M., Bédard, F., Biron, É., Tardif, M. R., Lacombe‐Barrios, J., & Bégin, P. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.05.038 · Cited by 145
Gyllfors, P., Bochenek, G., Overholt, J., Drupka, D., Kumlin, M., Sheller, J. R., Niżankowska, E., Isakson, P. C., Mejza, F., Lefkowith, J. B., et al. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.1450 · Cited by 143
Confino‐Cohen, R., Rosman, Y., Meir‐Shafrir, K., Stauber, T., Lachover‐Roth, I., Hershko, A. Y., & Goldberg, A. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2017.02.023 · Cited by 142
The impact of penicillin skin testing on clinical practice and antimicrobial stewardship
Rimawi, R. H., Cook, P., Gooch, M. D., Kabchi, B. A., Ashraf, M. S., Rimawi, B. H., Gebregziabher, M., & Siraj, D. S. (2013) · Journal of Hospital Medicine · doi:10.1002/jhm.2036 · Cited by 141
Tucker, M. H., Lomas, C. M., Ramchandar, N., & Waldram, J. D. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2017.01.023 · Cited by 141
Cephalosporin Allergy: Current Understanding and Future Challenges
Khan, D. A., Banerji, A., Bernstein, J. A., Bilgiçer, B., Blumenthal, K. G., Castells, M., Ein, D., Lang, D. M., & Phillips, E. J. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.06.001 · Cited by 140
Self-citationFirst-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing
Wolfson, A. R., Robinson, L. B., Li, L., McMahon, A. E., Cogan, A. S., Fu, X., Wickner, P. G., Samarakoon, U., Saff, R. R., Blumenthal, K. G., et al. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.06.010 · Cited by 140
Self-citationDetermining the negative predictive value of provocation tests with beta‐lactams
Demoly, P. M., Romano, A. G., Botelho, C., Bousquet-Rouanet, L., Gaeta, F., Silva, R., Rumi, G., Cernadas, J., & Bousquet, P. (2009) · Allergy · doi:10.1111/j.1398-9995.2009.02228.x · Cited by 139
Current Knowledge and Management of Hypersensitivity Reactions to Monoclonal Antibodies
Picard, M., & Galvão, V. R. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2016.12.001 · Cited by 139
Diagnosing immediate reactions to cephalosporins
Romano, A. G., Guéant‐Rodriguez, R., Viola, M., Amoghly, F., Gaeta, F., Nicolas, J. P., & Guéant, J. (2005) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2005.02317.x · Cited by 139
Commins, S. P., & Platts‐Mills, T. A. E. (2012) · Current Allergy and Asthma Reports · doi:10.1007/s11882-012-0315-y · Cited by 138
Kanny, G., Pichler, W. J., Morisset, M., Franck, P., Marie, B., Kohler, C., Renaudin, J., Beaudouin, É., Sainte‐Laudy, J., & Moneret‐Vautrin, D. A. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.09.012 · Cited by 138
Sousa‐Pinto, B., Blumenthal, K. G., Courtney, L. A., Mancini, C. M., & Jeffres, M. N. (2021) · JAMA Surgery · doi:10.1001/jamasurg.2021.0021 · Cited by 138
Self-citationAccuracy of penicillin allergy diagnostic tests: A systematic review and meta-analysis
Sousa‐Pinto, B., Tarrio, I., Blumenthal, K. G., Araújo, L. M., Azevedo, L. F., Delgado, L., & Fonseca, J. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.04.058 · Cited by 137
Self-citationActivation of T cells by carbamazepine and carbamazepine metabolites
Wu, Y., Sanderson, J. P., Farrell, J., Drummond, N. S., Hanson, A., Bowkett, E. R., Berry, N. G., Stachulski, A. V., Clarke, S. E., Pichler, W. J., et al. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.03.005 · Cited by 136
Yun, J. J., Mattsson, J., Schnyder, K., Fontana, S., Largiadèr, C. R., Pichler, W. J., & Yerly, D. (2013) · Clinical & Experimental Allergy · doi:10.1111/cea.12184 · Cited by 136
Anti-PEG IgE in anaphylaxis associated with polyethylene glycol
Zhou, Z., Stone, C. A., Jakubovic, B. D., Phillips, E. J., Sussman, G., Park, J., Hoang, U., Kirshner, S., Levin, R. L., & Kozlowski, S. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.11.011 · Cited by 134
Self-citationRapid oral challenge-desensitization for patients with aspirin-related urticaria-angioedema
Wong, J. T., Nagy, C. S., Krinzman, S. J., MacLean, J. A., & Bloch, K. J. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.104571 · Cited by 133
Park, M., Markus, P. J., Matešić, D., & Li, J. T. C. (2006) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)61100-3 · Cited by 133
Picard, M., Özyiğit, L. P., Caiado, J., Junior, P. F. G.-B., Galvão, V. R., Berlin, S. T., Campos, S. M., Matulonis, U. A., & Castells, M. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.10.039 · Cited by 132
Cox, L., Lieberman, P. L., Wallace, D. V., Simons, F. E. R., Finegold, I., Platts‐Mills, T. A. E., & Schwartz, L. B. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.04.010 · Cited by 131
Self-citationRomano, A. G., Viola, M., Guéant‐Rodriguez, R., Gaeta, F., Valluzzi, R. L., & Guéant, J. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-4-200702200-00005 · Cited by 130
Cross-reactivity between penicillins and cephalosporins: Clinical and immunologic studies
Blanca, M., Fernández, J., Miranda, A., Terrados, S., Torres, M. J., Vega, J. M. G., Ávila, M. J., Pérez‐Inestrosa, E., Garcia, J. J., & Suau, R. (1989) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(89)90122-x · Cited by 130
Drug-Induced Anaphylaxis Documented in Electronic Health Records
Dhopeshwarkar, N., Sheikh, A., Doan, R., Topaz, M., Bates, D. W., Blumenthal, K. G., & Zhou, L. (2018) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2018.06.010 · Cited by 127
Self-citationSaxon, A., Hassner, A., Swabb, E. A., Wheeler, B. J., & Adkinson, N. F. (1984) · The Journal of Infectious Diseases · doi:10.1093/infdis/149.1.16 · Cited by 126
HLA-DRB1*07:01 is associated with a higher risk of asparaginase allergies
Fernandez, C. A., Smith, C. J., Yang, W., Daté, M., Bashford, D., Larsen, E. C., Bowman, W. P., Liu, C., Ramsey, L. B., Chang, T. Y., et al. (2014) · Blood · doi:10.1182/blood-2014-03-563742 · Cited by 126
The Cost of Penicillin Allergy Evaluation
Blumenthal, K. G., Li, Y., Banerji, A., Yun, B. J., Long, A. A., & Walensky, R. P. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2017.08.006 · Cited by 125
Self-citationMustafa, S. S., Conn, K. M., & Ramsey, A. C. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.05.037 · Cited by 124
Topaz, M., Seger, D. L., Slight, S. P., Goss, F. R., Lai, K. H., Wickner, P. G., Blumenthal, K. G., Dhopeshwarkar, N., CHANG, F. Y., Bates, D. W., et al. (2015) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocv143 · Cited by 122
Self-citationAddressing Inpatient Beta-Lactam Allergies: A Multihospital Implementation
Blumenthal, K. G., Shenoy, E. S., Wolfson, A. R., Berkowitz, D. N., Carballo, V. A., Balekian, D. S., Marquis, K. A., Elshaboury, R. H., Gandhi, R. G., Meka, P., et al. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2017.02.019 · Cited by 122
Self-citationHesterberg, P. E., Banerji, A., Oren, E., Penson, R. T., Krasner, C. N., Seiden, M. V., & Wong, J. T. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.02.042 · Cited by 119
Self-citationJohnson, D. B., Reynolds, K. L., Sullivan, R. J., Balko, J. M., Patrinely, J. R., Cappelli, L. C., Naidoo, J., & Moslehi, J. J. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30107-8 · Cited by 118
Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
Chanprapaph, K., Vachiramon, V., & Rattanakaemakorn, P. (2014) · Dermatology Research and Practice · doi:10.1155/2014/734249 · Cited by 118
Cross sensitivity with acetaminophen in aspirin-sensitive subjects with asthma
Settipane, R. A., & Stevenson, D. D. (1989) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(89)90174-7 · Cited by 117
Penicillin skin testing in patients with a history of β-lactam allergy
Real, G., Rose, M. E., Ramirez-Atamoros, M. T., Hammel, J., Gordon, S. M., Arroliga, A. C., & Arroliga, M. E. (2007) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60882-4 · Cited by 116
Macy, E. M., Mangat, R., & Burchette, R. J. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.1385 · Cited by 114
Is There Cross-Reactivity Between Penicillins and Cephalosporins?
Apter, A. J., Kinman, J. L., Bilker, W. B., Herlim, M., Margolis, D. J., Lautenbach, E., Hennessy, S., & Strom, B. L. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.10.052 · Cited by 114
“Inactive” ingredients in oral medications
Reker, D., Blum, S. M., Steiger, C., Anger, K. E., Sommer, J. M., Fanikos, J. R., & Traverso, G. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau6753 · Cited by 114
The Effect of Penicillin Allergy Testing on Future Health Care Utilization: A Matched Cohort Study
Macy, E. M., & Shu, Y. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2017.02.012 · Cited by 113
Macy, E. M., Richter, P. K., Falkoff, R., & Zeiger, R. S. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70159-3 · Cited by 112
Successful parenteral desensitization to paclitaxel
Essayan, D. M., Kagey‐Sobotka, A., Colarusso, P., Lichtenstein, L. M., Ozols, R. F., & King, E. D. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)70281-6 · Cited by 109
Boulanger, J., Boursiquot, J.-N., Cournoyer, G., Lemieux, J., Masse, M. S., Almanric, K., & Guay, M. P. (2014) · Current Oncology · doi:10.3747/co.21.1966 · Cited by 107
Anaphylaxis to amoxycillin but good tolerance for benzyl penicillin
Blanca, M., Pérez, E., Garcia, J., et al. (1988) · Allergy · doi:10.1111/j.1398-9995.1988.tb01628.x · Cited by 106
Penicillin Allergy Testing Is Cost-Saving: An Economic Evaluation Study
Sousa‐Pinto, B., Blumenthal, K. G., Macy, E. M., Pereira, A. M., Azevedo, L. F., Delgado, L., & Fonseca, J. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa194 · Cited by 106
Self-citationPhillips, E. J., & Mallal, S. A. (2007) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e32825ea68a · Cited by 105
Self-citationCurrent Knowledge and Management of Hypersensitivity to Aspirin and NSAIDs
Laidlaw, T. M., & Cahill, K. N. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2016.10.021 · Cited by 105
Hayashi, H., Fukutomi, Y., Mitsui, C., 梶原, 景., Watai, K., Kamide, Y., Nakamura, Y., Hamada, Y., Tomita, Y., Sekiya, K., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201906-1215oc · Cited by 105
Hjortlund, J., Mortz, C. G., Skov, P. S., & Bindslev‐Jensen, C. (2013) · Allergy · doi:10.1111/all.12195 · Cited by 103
Anti-PEG Antibodies Inhibit the Anticoagulant Activity of PEGylated Aptamers
Moreno, A., Pitoc, G. A., Ganson, N. J., Layzer, J. M., Hershfield, M. S., Tarantal, A. F., & Sullenger, B. A. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.02.001 · Cited by 103
Banerji, A., Lax, T. P., Guyer, A. C., Hurwitz, S., Camargo, C. A., & Long, A. A. (2014) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2014.04.010 · Cited by 102
Self-citationBall, P. D., Stahlmann, R., Kubin, R., Choudhri, S., & Owens, R. C. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)90170-1 · Cited by 102
Acneiform Rash Induced by EGFR Inhibitors: Review of the Literature and New Insights
Fabbrocini, G., Panariello, L., Caro, G., & Cacciapuoti, S. (2015) · Skin Appendage Disorders · doi:10.1159/000371821 · Cited by 101
Romano, A. G., Gaeta, F., Valluzzi, R. L., Zaffiro, A., Caruso, C., & Quaratino, D. (2014) · Allergy · doi:10.1111/all.12390 · Cited by 100
Chiriac, A. M., Wang, Y., Schrijvers, R., Bousquet, P., Mura, T., Molinari, N., & Demoly, P. M. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2017.04.045 · Cited by 100
Research works printed but not linked: 175
- Khan, 2012, Cutaneous drug reactions, J Allergy Clin Immunol, 130, 1225, 10.1016/j.jaci.2012.08.007 · doi:10.1016/j.jaci.2012.08.007
- Barbaud, 2020, Intradermal tests with drugs: an approach to standardization, Front Med, 7, 156, 10.3389/fmed.2020.00156 · doi:10.3389/fmed.2020.00156
- Blumenthal, 2019, Recorded penicillin allergy and risk of mortality: a population-based matched cohort study, J Gen Intern Med, 34, 1685, 10.1007/s11606-019-04991-y · DOI
- García Rodríguez, 2019, Provocation tests in nonimmediate hypersensitivity reactions to β-lactam antibiotics in children: are extended challenges needed?, J Allergy Clin Immunol Pract, 7, 265, 10.1016/j.jaip.2018.06.023 · doi:10.1016/j.jaip.2018.06.023
- Gallardo, 2020, Sensitization phenotypes in immediate reactions to piperacillin-tazobactam, J Allergy Clin Immunol Pract, 8, 3175, 10.1016/j.jaip.2020.04.008 · doi:10.1016/j.jaip.2020.04.008
- Doña, 2020, Clinical characterization and diagnostic approaches for patients reporting hypersensitivity reactions to quinolones, J Allergy Clin Immunol Pract, 8, 2707, 10.1016/j.jaip.2020.04.051 · doi:10.1016/j.jaip.2020.04.051
- Cavkaytar, 2016, Testing for clarithromycin hypersensitivity: a diagnostic challenge in childhood, J Allergy Clin Immunol Pract, 4, 10.1016/j.jaip.2015.09.015 · doi:10.1016/j.jaip.2015.09.015
- Sala-Cunill, 2021, One-dilution rapid desensitization protocol to chemotherapeutic and biological agents: a five-year experience, J Allergy Clin Immunol Pract, 9, 4045, 10.1016/j.jaip.2021.06.024 · doi:10.1016/j.jaip.2021.06.024
- Weiss, 1992, Hypersensitivity reactions, Semin Oncol, 19, 458
- Trudeau, 1996, Docetaxel in patients with metastatic breast cancer: a phase II study of the National Cancer Institute of Canada-Clinical Trials Group, J Clin Oncol, 14, 422, 10.1200/JCO.1996.14.2.422 · doi:10.1200/jco.1996.14.2.422
- Sánchez-López, 2015, Successful oral desensitization in a patient with hypersensitivity reaction to crizotinib, J Investig Allergol Clin Immunol, 25, 307
- Madrigal-Burgaleta, 2019, A large single-hospital experience using drug provocation testing and rapid drug desensitization in hypersensitivity to antineoplastic and biological agents, J Allergy Clin Immunol Pract, 7, 618, 10.1016/j.jaip.2018.07.031 · doi:10.1016/j.jaip.2018.07.031
- Lehloenya, 2011, Outcomes of reintroducing anti-tuberculosis drugs following cutaneous adverse drug reactions, Int J Tuberc Lung Dis, 15, 1649, 10.5588/ijtld.10.0698 · doi:10.5588/ijtld.10.0698
- Karmacharya, 2015, Rituximab-induced serum sickness: a systematic review, Semin Arthritis Rheum, 45, 334, 10.1016/j.semarthrit.2015.06.014 · doi:10.1016/j.semarthrit.2015.06.014
- Foong, 2016, Lack of uniformity in the investigation and management of suspected beta-lactam allergy in children, Pediatr Allergy Immunol, 27, 527, 10.1111/pai.12557 · doi:10.1111/pai.12557
- Picard, 2014, A new humanized in vitro model of IgE-mediated rapid desensitization, Clin Transl Allergy, 4, O10, 10.1186/2045-7022-4-S3-O10 · doi:10.1186/2045-7022-4-s3-o10
- Chiriac, 2017, Optimal step doses for drug provocation tests to prove beta-lactam hypersensitivity, Allergy, 72, 552, 10.1111/all.13037 · doi:10.1111/all.13037
- Ozturk, 2013, Determining safe alternatives for multidrug hypersensitive patients with the alternative triple antibiotic-analgesic test, Allergol Immunopathol (Madr), 41, 189, 10.1016/j.aller.2012.01.007 · doi:10.1016/j.aller.2012.01.007
- Guvenir, 2016, Proven non-beta-lactam antibiotic allergy in children, Int Arch Allergy Immunol, 169, 45, 10.1159/000443830 · doi:10.1159/000443830
- Zambonino, 2014, Diagnostic evaluation of hypersensitivity reactions to beta-lactam antibiotics in a large population of children, Pediatr Allergy Immunol, 25, 80, 10.1111/pai.12155 · doi:10.1111/pai.12155
- Vezir, 2014, The evaluation of drug provocation tests in pediatric allergy clinic: a single center experience, Allergy Asthma Proc, 35, 156, 10.2500/aap.2014.35.3744 · doi:10.2500/aap.2014.35.3744
- Indradat, 2016, Provocation proven drug allergy in Thai children with adverse drug reactions, Asian Pac J Allergy Immunol, 34, 59
- Sompornrattanaphan, 2020, Fatal anaphylaxis from a second amoxicillin/clavulanic acid provocation after a prior negative provocation, J Allergy Clin Immunol Pract, 8, 752, 10.1016/j.jaip.2019.07.022 · doi:10.1016/j.jaip.2019.07.022
- Putterman, 1990, "Treating through" hypersensitivity to co-trimoxazole in AIDS patients, Lancet, 336, 52, 10.1016/0140-6736(90)91563-P · doi:10.1016/0140-6736(90)91563-p
- Trautmann, 2017, "Treating through" decision and follow-up in antibiotic therapy-associated exanthemas, J Allergy Clin Immunol Pract, 5, 1650, 10.1016/j.jaip.2017.03.032 · doi:10.1016/j.jaip.2017.03.032
- Trubiano, 2021, Treating through drug-associated exanthems in drug allergy management: current evidence and clinical aspects, J Allergy Clin Immunol Pract, 9, 2984, 10.1016/j.jaip.2021.04.008 · DOI
- Lehloenya, 2015, Lack of cross-toxicity between isoniazid and ethionamide in severe cutaneous adverse drug reactions: a series of 25 consecutive confirmed cases, J Antimicrob Chemother, 70, 2648, 10.1093/jac/dkv158 · doi:10.1093/jac/dkv158
- Garcia-Neuer, 2018, Drug-induced paradoxical vocal fold motion, J Allergy Clin Immunol Pract, 6, 90, 10.1016/j.jaip.2017.08.020 · doi:10.1016/j.jaip.2017.08.020
- Raley, 2020, Drug-associated inducible laryngeal obstruction complicating penicillin allergy testing, Ann Allergy Asthma Immunol, 125, 599, 10.1016/j.anai.2020.06.031 · doi:10.1016/j.anai.2020.06.031
- Phillips, 2019, Controversies in drug allergy: testing for delayed reactions, J Allergy Clin Immunol, 143, 66, 10.1016/j.jaci.2018.10.030 · doi:10.1016/j.jaci.2018.10.030
- Barbaud, 2014, Skin testing and patch testing in non-IgE-mediated drug allergy, Curr Allergy Asthma Rep, 14, 442, 10.1007/s11882-014-0442-8 · doi:10.1007/s11882-014-0442-8
- Alvarez-Arango, 2021, Vancomycin immediate skin responses in vancomycin-naïve subjects, Clin Exp Allergy, 51, 932, 10.1111/cea.13850 · doi:10.1111/cea.13850
- Klaewsongkram, 2019, Analysis of HLA-B allelic variation and IFN-gamma ELISpot responses in patients with severe cutaneous adverse reactions associated with drugs, J Allergy Clin Immunol Pract, 7, 219, 10.1016/j.jaip.2018.05.004 · DOI
- Suthumchai, 2018, The measurement of drug-induced interferon gamma-releasing cells and lymphocyte proliferation in severe cutaneous adverse reactions, J Eur Acad Dermatol Venereol, 32, 992, 10.1111/jdv.14890 · doi:10.1111/jdv.14890
- Trubiano, 2017, Drug-specific upregulation of CD137 on CD8+ T cells aids in the diagnosis of multiple antibiotic toxic epidermal necrolysis, J Allergy Clin Immunol Pract, 5, 823, 10.1016/j.jaip.2016.09.043 · doi:10.1016/j.jaip.2016.09.043
- Fernandez, 2015, Genome-wide analysis links NFATC2 with asparaginase hypersensitivity, Blood, 126, 69, 10.1182/blood-2015-02-628800 · doi:10.1182/blood-2015-02-628800
- Khan, 2020, Pharmacogenomic biomarkers in allergy and immunology practice, J Allergy Clin Immunol, 146, 509, 10.1016/j.jaci.2020.05.050 · doi:10.1016/j.jaci.2020.05.050
- Macy, 2011, Reply. J Allergy Clin Immunol, 128, 686, 10.1016/j.jaci.2011.04.055 · doi:10.1016/j.jaci.2011.04.055
- Levine, 1967, Prediction of penicillin allergy by immunological tests, Ann N Y Acad Sci, 145, 298, 10.1111/j.1749-6632.1967.tb50227.x · doi:10.1111/j.1749-6632.1967.tb50227.x
- Ibia, 2000, Antibiotic rashes in children: a survey in a private practice setting, Arch Dermatol, 136, 849, 10.1001/archderm.136.7.849 · doi:10.1001/archderm.136.7.849
- Kerns, 1973, Ampicillin rash in children: relationship to penicillin allergy and infectious mononucleosis, Am J Dis Child, 125, 187, 10.1001/archpedi.1973.04160020023004 · doi:10.1001/archpedi.1973.04160020023004
- Patel, 1967, Skin rash with infectious mononucleosis and ampicillin, Pediatrics, 40, 910, 10.1542/peds.40.5.910 · doi:10.1542/peds.40.5.910
- Zhang, 2019, Drug-induced severe cutaneous adverse reactions: determine the cause and prevention, Ann Allergy Asthma Immunol, 123, 483, 10.1016/j.anai.2019.08.004 · doi:10.1016/j.anai.2019.08.004
- Marcos Bravo, 1995, Hypersensitivity to cefuroxime with good tolerance to other betalactams, Allergy, 50, 359, 10.1111/j.1398-9995.1995.tb01160.x · doi:10.1111/j.1398-9995.1995.tb01160.x
- Poston, 2004, Cefazolin tolerance does not predict ceftriaxone hypersensitivity: unique side chains precipitate anaphylaxis, Pharmacotherapy, 24, 668, 10.1592/phco.24.6.668.34753 · doi:10.1592/phco.24.6.668.34753
- Testi, 2010, Nonirritating concentration for skin testing with cephalosporins, J Investig Allergol Clin Immunol, 20, 171
- Koo, 2022, Retrospective stratification of cephalosporin allergy label risk using validated penicillin allergy frameworks, J Allergy Clin Immunol Pract, 10, 2472, 10.1016/j.jaip.2022.05.032 · doi:10.1016/j.jaip.2022.05.032
- Pedersen-Bjergaard, 1967, Cephalothin in the treatment of penicillin sensitive patients, Acta Allergol, 22, 299, 10.1111/j.1398-9995.1967.tb03226.x · doi:10.1111/j.1398-9995.1967.tb03226.x
- Shepherd, 1993, Administration of cephalosporin antibiotics to patients with a history of penicillin allergy, J Allergy Clin Immunol Pract, 91, 262
- Chiron, 2020, Allergy to third- and second-generation cephalosporins in confirmed penicillin-allergic patients, J Allergy Clin Immunol Pract, 8, 2409, 10.1016/j.jaip.2020.03.021 · doi:10.1016/j.jaip.2020.03.021
- Li, 2019, Cross-reactivity to penicillins in cephalosporin anaphylaxis, Br J Anaesth, 123, e532, 10.1016/j.bja.2019.09.011 · doi:10.1016/j.bja.2019.09.011
- Sodhi, 2004, Is it safe to use carbapenems in patients with a history of allergy to penicillin?, J Antimicrob Chemother, 54, 1155, 10.1093/jac/dkh454 · doi:10.1093/jac/dkh454
- Prescott, 2004, Incidence of carbapenem-associated allergic-type reactions among patients with versus patients without a reported penicillin allergy, Clin Infect Dis, 38, 1102, 10.1086/382880 · doi:10.1086/382880
- McConnell, 2000, Incidence of imipenem hypersensitivity reactions in febrile neutropenic bone marrow transplant patients with a history of penicillin allergy, Clin Infect Dis, 31, 1512, 10.1086/317507 · doi:10.1086/317507
- Sanchez-Borges, 2001, Tolerability to new COX-2 inhibitors in NSAID-sensitive patients with cutaneous reactions, Ann Allergy Asthma Immunol, 87, 201, 10.1016/S1081-1206(10)62226-0 · doi:10.1016/s1081-1206(10)62226-0
- Kula, 2014, A systematic review: can one prescribe carbapenems to patients with IgE-mediated allergy to penicillins or cephalosporins?, Clin Infect Dis, 59, 1113, 10.1093/cid/ciu587 · doi:10.1093/cid/ciu587
- Adkinson, 1990, Immunogenicity and cross-allergenicity of aztreonam, Am J Med, 88, S3
- Saxon, 1985, Investigation into the immunologic cross-reactivity of aztreonam with other beta-lactam antibiotics, Am J Med, 78, 19, 10.1016/0002-9343(85)90198-6 · doi:10.1016/0002-9343(85)90198-6
- Graninger, 1985, Aztreonam efficacy in difficult-to-treat infections and tolerance in patients with beta-lactam hypersensitivity, Chemioterapia, 4, 64
- Adkinson, 1984, Immunology of the monobactam aztreonam, Antimicrob Agents Chemother, 25, 93, 10.1128/AAC.25.1.93 · doi:10.1128/aac.25.1.93
- Adkinson, 1985, Cross-allergenicity and immunogenicity of aztreonam, Rev Infect Dis, 7, S613, 10.1093/clinids/7.Supplement_4.S613 · doi:10.1093/clinids/7.supplement_4.s613
- Vaisman, 2017, Clarifying a "penicillin" allergy: a teachable moment, JAMA Intern Med, 177, 269, 10.1001/jamainternmed.2016.8185 · doi:10.1001/jamainternmed.2016.8185
- Belchi-Hernandez, 1996, Management of adverse reactions to prophylactic trimethoprim-sulfamethoxazole in patients with human immunodeficiency virus infection, Ann Allergy Asthma Immunol, 76, 355, 10.1016/S1081-1206(10)60037-3 · doi:10.1016/s1081-1206(10)60037-3
- Ozkaya-Bayazit, 1999, Topical provocation in 27 cases of cotrimoxazole-induced fixed drug eruption, Contact Dermatitis, 41, 185, 10.1111/j.1600-0536.1999.tb06127.x · doi:10.1111/j.1600-0536.1999.tb06127.x
- Bonfanti, 2000, The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: a randomized multicentric study. CISAI Group, Biomed Pharmacother, 54, 45, 10.1016/S0753-3322(00)88640-0 · doi:10.1016/s0753-3322(00)88640-0
- Straatmann, 2002, A randomized, pilot trial comparing full versus escalating dose regimens for the desensitization of AIDS patients allergic to sulfonamides, Braz J Infect Dis, 6, 276, 10.1590/S1413-86702002000600002 · doi:10.1590/s1413-86702002000600002
- Leoung, 2001, Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis Carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ, J Infect Dis, 184, 992, 10.1086/323353 · doi:10.1086/323353
- Gluckstein, 1995, Rapid oral desensitization to trimethoprim-sulfamethoxazole (TMP-SMZ): use in prophylaxis for Pneumocystis carinii pneumonia in patients with AIDS who were previously intolerant to TMP-SMZ, Clin Infect Dis, 20, 849, 10.1093/clinids/20.4.849 · doi:10.1093/clinids/20.4.849
- Hughes, 1986, Co-trimoxazole desensitization in bone marrow transplantation, Ann Intern Med, 105, 148, 10.7326/0003-4819-105-1-148 · doi:10.7326/0003-4819-105-1-148
- Soffritti, 2003, Successful desensitization to trimethoprim-sulfamethoxazole after allogeneic haematopoietic stem cell transplantation: preliminary observations, Med Pediatr Oncol, 40, 271, 10.1002/mpo.10196 · doi:10.1002/mpo.10196
- Krantz, 2021, Reply to “The safety and efficacy of direct oral challenge in trimethoprim-sulfamethoxazole antibiotic allergy”, J Allergy Clin Immunol Pract, 9, 3849, 10.1016/j.jaip.2021.07.027 · doi:10.1016/j.jaip.2021.07.027
- Ball, 2004, A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context, Int J Antimicrob Agents, 23, 421, 10.1016/j.ijantimicag.2004.02.014 · doi:10.1016/j.ijantimicag.2004.02.014
- Manfredi, 2004, Detection of specific IgE to quinolones, J Allergy Clin Immunol, 113, 155, 10.1016/j.jaci.2003.09.035 · doi:10.1016/j.jaci.2003.09.035
- Venturini Diaz, 2017, In vivo diagnostic tests in adverse reactions to quinolones, J Investig Allergol Clin Immunol, 17, 393
- Anovadiya, 2011, Cross sensitivity between ciprofloxacin and levofloxacin for an immediate hypersensitivity reaction, J Pharmacol Pharmacother, 2, 187, 10.4103/0976-500X.83285 · doi:10.4103/0976-500x.83285
- Davila, 1993, Cross-reactivity between quinolones: report of three cases, Allergy, 48, 388, 10.1111/j.1398-9995.1993.tb02413.x · doi:10.1111/j.1398-9995.1993.tb02413.x
- Gonzalez-Mancebo, 2004, Immediate hypersensitivity to levofloxacin diagnosed through skin prick test, Ann Pharmacother, 38, 354, 10.1345/aph.1D159 · doi:10.1345/aph.1d159
- Lobera, 2010, Allergy to quinolones: low cross-reactivity to levofloxacin, J Investig Allergol Clin Immunol, 20, 607
- Sanchez-Morillas, 2010, Systemic anaphylaxis caused by moxifloxacin, Allergol Immunopathol (Madr), 38, 226, 10.1016/j.aller.2009.09.008 · doi:10.1016/j.aller.2009.09.008
- Demir, 2017, Usefulness of in vivo and in vitro diagnostic tests in the diagnosis of hypersensitivity reactions to quinolones and in the evaluation of cross-reactivity: a comprehensive study including the latest quinolone gemifloxacin, Allergy Asthma Immunol Res, 9, 347, 10.4168/aair.2017.9.4.347 · doi:10.4168/aair.2017.9.4.347
- Gea-Banacloche, 1996, Ciprofloxacin desensitization, J Allergy Clin Immunol, 97, 1426, 10.1016/S0091-6749(96)70218-X · doi:10.1016/s0091-6749(96)70218-x
- Lantner, 1995, Ciprofloxacin desensitization in a patient with cystic fibrosis, J Allergy Clin Immunol, 96, 1001, 10.1016/S0091-6749(95)70240-7 · doi:10.1016/s0091-6749(95)70240-7
- Treadway, 1996, Paediatric safety of azithromycin: worldwide experience, J Antimicrob Chemother, 37, 143, 10.1093/jac/37.suppl_C.143 · doi:10.1093/jac/37.suppl_c.143
- van der Linden, 1998, Skin reactions to antibacterial agents in general practice, J Clin Epidemiol, 51, 703, 10.1016/S0895-4356(98)00041-9 · doi:10.1016/s0895-4356(98)00041-9
- Benahmed, 2004, The accuracy of the diagnosis of suspected macrolide antibiotic hypersensitivity: results of a single-blinded trial, Allergy, 59, 1130, 10.1111/j.1398-9995.2004.00638.x · doi:10.1111/j.1398-9995.2004.00638.x
- Lammintausta, 2005, Oral challenge in patients with suspected cutaneous adverse drug reactions: findings in 784 patients during a 25-year-period, Acta Derm Venereol, 85, 491, 10.1080/00015550510042859 · doi:10.1080/00015550510042859
- Mori, 2010, Sensitivity and specificity of skin tests in the diagnosis of clarithromycin allergy, Ann Allergy Asthma Immunol, 104, 417, 10.1016/j.anai.2010.03.010 · doi:10.1016/j.anai.2010.03.010
- Laurie, 2000, Successful clarithromycin desensitization in a macrolide-sensitive patient (abstract), Ann Allergy Asthma Immunol, 84, 116
- Asero, 2005, Oral aspirin challenges in patients with a history of intolerance to single non-steroidal anti-inflammatory drugs, Clin Exp Allergy, 35, 713, 10.1111/j.1365-2222.2005.2228.x · doi:10.1111/j.1365-2222.2005.2228.x
- Asero, 2006, Use of ketoprofen oral challenges to detect cross-reactors among patients with a history of aspirin-induced urticaria, Ann Allergy Asthma Immunol, 97, 187, 10.1016/S1081-1206(10)60011-7 · doi:10.1016/s1081-1206(10)60011-7
- Kim, 2007, The prevalence of Samter's triad in patients undergoing functional endoscopic sinus surgery, Ear Nose Throat J, 86, 396, 10.1177/014556130708600715 · doi:10.1177/014556130708600715
- Dursun, 2008, Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis, Ann Allergy Asthma Immunol, 100, 420, 10.1016/S1081-1206(10)60465-6 · doi:10.1016/s1081-1206(10)60465-6
- Cook, 2017, Use of a composite symptom score during challenge in patients with suspected aspirin-exacerbated respiratory disease, Ann Allergy Asthma Immunol, 118, 597, 10.1016/j.anai.2017.02.016 · doi:10.1016/j.anai.2017.02.016
- Staso, 2021, Scoring tool for systemic symptoms during aspirin challenge detects mediator production in aspirin-exacerbated respiratory disease, Ann Allergy Asthma Immunol, 127, 131, 10.1016/j.anai.2021.03.025 · doi:10.1016/j.anai.2021.03.025
- White, 2013, The clinical dilemma of "silent desensitization" in aspirin-exacerbated respiratory disease, Allergy Asthma Proc, 34, 378, 10.2500/aap.2013.34.3670 · doi:10.2500/aap.2013.34.3670
- Lang, 2018, Omalizumab can inhibit respiratory reaction during aspirin desensitization, Ann Allergy Asthma Immunol, 121, 98, 10.1016/j.anai.2018.05.007 · doi:10.1016/j.anai.2018.05.007
- Huang, 2019, Sinus surgery improves lower respiratory tract reactivity during aspirin desensitization for AERD, J Allergy Clin Immunol Pract, 7, 1647, 10.1016/j.jaip.2019.02.037 · doi:10.1016/j.jaip.2019.02.037
- Chen, 2015, An hourly dose-escalation desensitization protocol for aspirin-exacerbated respiratory disease, J Allergy Clin Immunol Pract, 3, 926, 10.1016/j.jaip.2015.06.013 · doi:10.1016/j.jaip.2015.06.013
- Lee, 2010, Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease, Ann Allergy Asthma Immunol, 105, 130, 10.1016/j.anai.2010.05.020 · doi:10.1016/j.anai.2010.05.020
- DeGregorio, 2019, A 1-day, 90-minute aspirin challenge and desensitization protocol in aspirin-exacerbated respiratory disease, J Allergy Clin Immunol Pract, 7, 1174, 10.1016/j.jaip.2018.10.032 · doi:10.1016/j.jaip.2018.10.032
- Pelletier, 2019, Comparable safety of 2 aspirin desensitization protocols for aspirin exacerbated respiratory disease, J Allergy Clin Immunol Pract, 7, 1319, 10.1016/j.jaip.2018.08.004 · doi:10.1016/j.jaip.2018.08.004
- Pleskow, 1982, Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory period, J Allergy Clin Immunol, 69, 11, 10.1016/0091-6749(82)90081-1 · DOI
- Wangberg, 2021, Perioperative management and perceived risks of sinus surgery in patients with aspirin-exacerbated respiratory disease, Int Forum Allergy Rhinol, 11, 1132, 10.1002/alr.22789 · doi:10.1002/alr.22789
- Do, 2019, Long-term assessment of aspirin desensitization shows successful bridging with non-aspirin nonsteroidal anti-inflammatory drugs for procedures, Allergy Asthma Proc, 40, 311, 10.2500/aap.2019.40.4239 · doi:10.2500/aap.2019.40.4239
- White, 2005, The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease, Ann Allergy Asthma Immunol, 95, 330, 10.1016/S1081-1206(10)61150-7 · doi:10.1016/s1081-1206(10)61150-7
- White, 2006, Effect of leukotriene modifier drugs on the safety of oral aspirin challenges, Ann Allergy Asthma Immunol, 97, 688, 10.1016/S1081-1206(10)61101-5 · doi:10.1016/s1081-1206(10)61101-5
- Kowalski, 1986, Clinical efficacy of aspirin in "desensitised" aspirin-sensitive asthmatics, Eur J Respir Dis, 69, 219
- Cho, 2014, Long-term sinonasal outcomes of aspirin desensitization in aspirin exacerbated respiratory disease, Otolaryngol Head Neck Surg, 151, 575, 10.1177/0194599814545750 · doi:10.1177/0194599814545750
- Sánchez-Borges, 2015, Aspirin-exacerbated cutaneous disease (AECD) is a distinct subphenotype of chronic spontaneous urticaria, J Eur Acad Dermatol Venereol, 29, 698, 10.1111/jdv.12658 · doi:10.1111/jdv.12658
- Asero, 2002, Autoreactivity is highly prevalent in patients with multiple intolerances to NSAIDs, Ann Allergy Asthma Immunol, 88, 468, 10.1016/S1081-1206(10)62384-8 · doi:10.1016/s1081-1206(10)62384-8
- Asero, 2003, Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria, J Allergy Clin Immunol, 111, 1095, 10.1067/mai.2003.1444 · doi:10.1067/mai.2003.1444
- Perrone, 2003, Tolerability of rofecoxib in patients with adverse reactions to nonsteroidal anti-inflammatory drugs: a study of 216 patients and literature review, Int Arch Allergy Immunol, 132, 82, 10.1159/000073268 · doi:10.1159/000073268
- Nettis, 2002, Tolerability of rofecoxib in patients with cutaneous adverse reactions to nonsteroidal anti-inflammatory drugs, Ann Allergy Asthma Immunol, 88, 331, 10.1016/S1081-1206(10)62017-0 · doi:10.1016/s1081-1206(10)62017-0
- Sánchez, 2020, Clinical control of CSU with antihistamines allows for tolerance of NSAID-exacerbated cutaneous disease, J Allergy Clin Immunol Pract, 8, 3577, 10.1016/j.jaip.2020.06.057 · doi:10.1016/j.jaip.2020.06.057
- Walters, 2016, Tolerance to nonsteroidal anti-inflammatory drugs and alcohol after omalizumab treatment in a patient with chronic urticaria, Ann Allergy Asthma Immunol, 117, 559, 10.1016/j.anai.2016.08.020 · doi:10.1016/j.anai.2016.08.020
- Asero, 2018, Restoration of aspirin tolerance following omalizumab treatment in a patient with chronic spontaneous urticaria, Eur Ann Allergy Clin Immunol, 50, 226, 10.23822/EurAnnACI.1764-1489.36 · doi:10.23822/eurannaci.1764-1489.36
- Doña, 2017, Natural evolution in patients with nonsteroidal anti-inflammatory drug-induced urticaria/angioedema, Allergy, 72, 1346, 10.1111/all.13147 · doi:10.1111/all.13147
- Doña, 2014, NSAID-induced urticaria/angioedema does not evolve into chronic urticaria: a 12-year follow-up study, Allergy, 69, 438, 10.1111/all.12335 · doi:10.1111/all.12335
- Goksel, 2010, Safety of meloxicam in patients with aspirin/non-steroidal anti-inflammatory drug-induced urticaria and angioedema, J Dermatol, 37, 973, 10.1111/j.1346-8138.2010.00948.x · doi:10.1111/j.1346-8138.2010.00948.x
- Rossini, 2008, Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation, Am J Cardiol, 101, 786, 10.1016/j.amjcard.2007.10.045 · doi:10.1016/j.amjcard.2007.10.045
- Silberman, 2005, Rapid desensitization procedure for patients with aspirin hypersensitivity undergoing coronary stenting, Am J Cardiol, 95, 509, 10.1016/j.amjcard.2004.10.022 · doi:10.1016/j.amjcard.2004.10.022
- Moore, 1980, Nonsteroidal anti-inflammatory intolerance. an anaphylactic reaction to tolmetin, Arch Intern Med, 140, 1105, 10.1001/archinte.1980.00330190117037 · doi:10.1001/archinte.1980.00330190117037
- Alkhawajah, 1993, Fatal anaphylactic reaction to diclofenac, Forensic Sci Int, 60, 107, 10.1016/0379-0738(93)90098-U · doi:10.1016/0379-0738(93)90098-u
- Himly, 2003, IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone, J Allergy Clin Immunol, 111, 882, 10.1067/mai.2003.163 · doi:10.1067/mai.2003.163
- Couto, 2012, IgE-mediated metamizol allergy and the usefulness of the cellular allergen stimulation test, Eur Ann Allergy Clin Immunol, 44, 113
- Fontaine, 2005, Anaphylactic shock caused by a selective allergy to celecoxib, with no allergy to rofecoxib or sulfamethoxazole, J Allergy Clin Immunol, 115, 633, 10.1016/j.jaci.2004.10.045 · doi:10.1016/j.jaci.2004.10.045
- Cortellini, 2017, Clinical approach on challenge and desensitization procedures with aspirin in patients with ischemic heart disease and nonsteroidal anti-inflammatory drug hypersensitivity, Allergy, 72, 498, 10.1111/all.13068 · doi:10.1111/all.13068
- Gendernalik, 2009, Fixed drug eruptions: a case report and review of the literature, Cutis, 84, 215
- Blanca-López, 2018, Acetyl salicylic acid challenge in children with hypersensitivity reactions to nonsteroidal anti-inflammatory drugs differentiates between cross-intolerant and selective responders, J Allergy Clin Immunol Pract, 6, 1226, 10.1016/j.jaip.2017.08.029 · doi:10.1016/j.jaip.2017.08.029
- Mori, 2020, A multicenter retrospective study on hypersensitivity reactions to nonsteroidal anti-inflammatory drugs (NSAIDs) in children: a report from the European Network on Drug Allergy (ENDA) Group, J Allergy Clin Immunol Pract, 8, 1022, 10.1016/j.jaip.2019.10.049 · doi:10.1016/j.jaip.2019.10.049
- Cousin, 2016, Phenotypical characterization of children with hypersensitivity reactions to NSAIDs, Pediatr Allergy Immunol, 27, 743, 10.1111/pai.12596 · doi:10.1111/pai.12596
- Camara, 2005, Clopidogrel (Plavix) desensitization: a case series, Catheter Cardiovasc Interv, 65, 525
- Camara, 2007, Clopidogrel (Plavix) desensitization protocol, Catheter Cardiovasc Interv, 69, 154
- Makrilia, 2010, Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review, Met Based Drugs, 2010, 10.1155/2010/207084 · doi:10.1155/2010/207084
- Shibata, 2009, Oxaliplatin-induced allergic reaction in patients with colorectal cancer in Japan, Int J Clin Oncol, 14, 397, 10.1007/s10147-009-0883-6 · doi:10.1007/s10147-009-0883-6
- Pellegrino, 2017, Nab-paclitaxel after docetaxel hypersensitivity reaction: case report and literature review, Acta Biomed, 88, 329
- Tsao, 2022, Hypersensitivity reactions to platinum agents and taxanes, Clin Rev Allergy Immunol, 62, 432, 10.1007/s12016-021-08877-y · DOI
- Pasteur, 2019, Low cross-reactivity between cisplatin and other platinum salts, J Allergy Clin Immunol Pract, 7, 1894, 10.1016/j.jaip.2019.01.057 · doi:10.1016/j.jaip.2019.01.057
- Sánchez-Muñoz, 2011, Cross-sensitivity between taxanes in patients with breast cancer, Clin Transl Oncol, 13, 904, 10.1007/s12094-011-0753-3 · doi:10.1007/s12094-011-0753-3
- Dizon, 2006, Cross-sensitivity between paclitaxel and docetaxel in a women's cancers program, Gynecol Oncol, 100, 149, 10.1016/j.ygyno.2005.08.004 · doi:10.1016/j.ygyno.2005.08.004
- Koren, 2002, Hypersensitivity reaction to cisplatin during chemoradiation therapy for gynecologic malignancy, Am J Clin Oncol, 25, 625, 10.1097/00000421-200212000-00020 · doi:10.1097/00000421-200212000-00020
- Polyzos, 2009, Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience, Oncology, 76, 36, 10.1159/000178163 · doi:10.1159/000178163
- Syrigou, 2010, Administration of cisplatin in three patients with carboplatin hypersensitivity: is skin testing useful?, Anticancer Drugs, 21, 333, 10.1097/CAD.0b013e32833418c0 · doi:10.1097/cad.0b013e32833418c0
- Leguy-Seguin, 2007, Diagnostic and predictive value of skin testing in platinum salt hypersensitivity, J Allergy Clin Immunol, 119, 726, 10.1016/j.jaci.2006.11.640 · doi:10.1016/j.jaci.2006.11.640
- Koshiba, 2009, Incidence of Carboplatin-related hypersensitivity reactions in Japanese patients with gynecologic malignancies, Int J Gynecol Cancer, 19, 460, 10.1111/IGC.0b013e3181a1bf2e · doi:10.1111/igc.0b013e3181a1bf2e
- Goldberg, 1996, A modified, prolonged desensitization protocol in carboplatin allergy, J Allergy Clin Immunol, 98, 841, 10.1016/S0091-6749(96)70134-3 · doi:10.1016/s0091-6749(96)70134-3
- Gomez, 2009, Carboplatin hypersensitivity: does introduction of skin test and desensitization reliably predict and avoid the problem? A prospective single-center study, Int J Gynecol Cancer, 19, 1284, 10.1111/IGC.0b013e3181a418ff · doi:10.1111/igc.0b013e3181a418ff
- Levin, 2020, Platin risk stratification algorithm with modified intradermal skin test protocol, J Allergy Clin Immunol Pract, 8, 1139, 10.1016/j.jaip.2019.08.055 · doi:10.1016/j.jaip.2019.08.055
- Chung, 2018, A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity, Cancer Chemother Pharmacol, 82, 777, 10.1007/s00280-018-3662-0 · doi:10.1007/s00280-018-3662-0
- Madrigal-Burgaleta, 2013, Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment, Allergy, 68, 853, 10.1111/all.12105 · doi:10.1111/all.12105
- Alvarez-Cuesta, 2015, Delving into cornerstones of hypersensitivity to antineoplastic and biological agents: value of diagnostic tools prior to desensitization, Allergy, 70, 784, 10.1111/all.12620 · doi:10.1111/all.12620
- Otani, 2018, Utility of risk stratification for paclitaxel hypersensitivity reactions, J Allergy Clin Immunol Pract, 6, 1266, 10.1016/j.jaip.2017.08.025 · doi:10.1016/j.jaip.2017.08.025
- De Lira-Quezada, 2018, Early and delayed hypersensitivity reactions to paclitaxel: desensitization as a challenge, Ann Allergy Asthma Immunol, 121, S72, 10.1016/j.anai.2018.09.234 · doi:10.1016/j.anai.2018.09.234
- Horvat, 2016, The use of Erwinia asparaginase for adult patients with acute lymphoblastic leukemia after pegaspargase intolerance, Leuk Res, 50, 17, 10.1016/j.leukres.2016.08.014 · doi:10.1016/j.leukres.2016.08.014
- August, 2020, Desensitization to pegaspargase in children with acute lymphoblastic leukemia and lymphoblastic lymphoma, Pediatr Blood Cancer, 67, 10.1002/pbc.28021 · doi:10.1002/pbc.28021
- Sato, 2020, Osimertinib-associated toxic epidermal necrolysis in a lung cancer patient harboring an EGFR mutation—a case report and a review of the literature, Medicina (Kaunas), 56, 403, 10.3390/medicina56080403 · doi:10.3390/medicina56080403
- Pasadyn, 2020, Cutaneous adverse effects of biologic medications, Cleve Clin J Med, 87, 288, 10.3949/ccjm.87a.19119 · doi:10.3949/ccjm.87a.19119
- Iimura, 2018, NSAIDs may prevent EGFR-TKI-related skin rash in non-small cell lung cancer patients, Int J Clin Pharmacol Ther, 56, 551, 10.5414/CP203323 · doi:10.5414/cp203323
- Makino, 2013, Treatment strategy for reducing the risk of rituximab-induced cytokine release syndrome in patients with intravascular large B-cell lymphoma: a case report and review of the literature, J Med Case Rep, 7, 280, 10.1186/1752-1947-7-280 · doi:10.1186/1752-1947-7-280
- Gold, 2017, Premedication use in preventing acute infliximab infusion reactions in patients with inflammatory bowel disease: a single center cohort study, Inflamm Bowel Dis, 23, 1882, 10.1097/MIB.0000000000001189 · doi:10.1097/mib.0000000000001189
- Rocchi, 2014, Hypersensitivity reactions to tocilizumab: role of skin tests in diagnosis, Rheumatology (Oxford), 53, 1527, 10.1093/rheumatology/keu181 · doi:10.1093/rheumatology/keu181
- Cansever, 2018, Successful slow desensitization to tocilizumab in a 15-year-old patient, J Investig Allergol Clin Immunol, 28, 436, 10.18176/jiaci.0314 · doi:10.18176/jiaci.0314
- Sakaue, 2014, Tocilizumab-induced leucocytoclastic vasculitis in a patient with rheumatoid arthritis, Rheumatology (Oxford), 53, 1529, 10.1093/rheumatology/keu008 · doi:10.1093/rheumatology/keu008
- Cortellini, 2018, Effective desensitization to tocilizumab in delayed hypersensitivity reaction, Pharmacology, 102, 114, 10.1159/000490419 · doi:10.1159/000490419
- Weiss, 2020, A case of serum sickness-like reaction in an adult treated with omalizumab, Mil Med, 185, e912, 10.1093/milmed/usz357 · doi:10.1093/milmed/usz357
- Jeimy, 2019, Dermatomyositis associated with omalizumab therapy for severe asthma: a case report, Allergy Asthma Clin Immunol, 15, 4, 10.1186/s13223-019-0319-4 · doi:10.1186/s13223-019-0319-4
- Brockow, 2021, "Idiopathic" anaphylaxis caused by carboxymethylcellulose in ice cream, J Allergy Clin Immunol Pract, 9, 555, 10.1016/j.jaip.2020.10.051 · doi:10.1016/j.jaip.2020.10.051
- Klein, 1998, Anaphylaxis from the carboxymethylcellulose component of barium sulfate suspension, N Engl J Med, 338, 623, 10.1056/NEJM199802263380915 · doi:10.1056/nejm199802263380915
- Ohnishi, 2019, Anaphylaxis to carboxymethylcellulose: add food additives to the list of elicitors, Pediatrics, 143, 10.1542/peds.2018-1180 · doi:10.1542/peds.2018-1180
- Bircher, 2004, Oral tolerance of carboxymethylcellulose in patients with anaphylaxis to parenteral carboxymethylcellulose, Ann Allergy Asthma Immunol, 92, 580, 10.1016/S1081-1206(10)61769-3 · doi:10.1016/s1081-1206(10)61769-3
- Garcia-Ortega, 2003, Carboxymethylcellulose allergy as a cause of suspected corticosteroid anaphylaxis, Ann Allergy Asthma Immunol, 91, 421, 10.1016/S1081-1206(10)61698-5 · doi:10.1016/s1081-1206(10)61698-5
- Rutkowski, 2020, Immediate hypersensitivity reactions to steroids and steroid containing medications, Curr Opin Allergy Clin Immunol, 20, 362, 10.1097/ACI.0000000000000655 · doi:10.1097/aci.0000000000000655
- Bonanni, 2021, Anaphylaxis after injecting a hemostatic agent containing gelatin into vertebral bone under pressure-a warning, Spine Deform, 9, 1191, 10.1007/s43390-020-00273-4 · doi:10.1007/s43390-020-00273-4
- Aminsharifi, 2019, Major complications and adverse events related to the injection of the SpaceOAR hydrogel system before radiotherapy for prostate cancer: review of the manufacturer and user facility device experience database, J Endourol, 33, 868, 10.1089/end.2019.0431 · doi:10.1089/end.2019.0431
- Scheman, 2018, Contact allergy to propylene glycol and cross-reactions, Dermatitis, 29, 350, 10.1097/DER.0000000000000416 · doi:10.1097/der.0000000000000416
Cited by
Hardin, H., Shao, W., & Bernstein, J. A. (2023) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2023.08.022 · Cited by 10
Self-citation
Metadata
- Authors
- Khan, D. A., Banerji, A., Blumenthal, K. G., Phillips, E. J., Solensky, R., White, A. A., Bernstein, J. A., Chu, D. K., Ellis, A. K., Golden, D. B. K., Greenhawt, M. J., Horner, C. C., Ledford, D., Lieberman, J. A., Oppenheimer, J., Rank, M. A., Shaker, M. S., Stukus, D. R., Wallace, D., Wang, J., Khan, D. A., Golden, D. B. K., Shaker, M., Stukus, D. R., Khan, D. A., Banerji, A., Blumenthal, K. G., Phillips, E. J., Solensky, R., White, A. A., Bernstein, J. A., Chu, D. K., Ellis, A. K., Golden, D. B. K., Greenhawt, M. J., Horner, C. C., Ledford, D., Lieberman, J. A., Oppenheimer, J., Rank, M. A., Shaker, M. S., Stukus, D. R., Wallace, D., & Wang, J.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2022-12
- Volume
- 150
- Issue
- 6
- Pages
- 1333-1393
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W4296178925
- Cited by
- 563
- References
- 418
- FWCI
- 48.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (am, 369 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.